
Eximore
Biopharmaceutical company developing innovative punctal plug technology for eye disease therapies.
About
Eximore Ltd is a biopharmaceutical company focused on the development, and commercialization of our innovative proprietary "pack and release" punctal plug technology therapy for diseases of the eye. Eximore is positioned to become a central player in the ophthalmic space due to our ability to create drug delivery solutions that reduce the complexity and burden of the current eye drops standard of care by developing a non-invasive, sustained-release alternative. With a focus on advancing our Glaucoma and Dry Eye products through to Phase 2 clinical trials, our goal is to overcome the issues of patient adherence and compliance by providing means of more consistent and reliable drug dosing for better patient outcomes.
Listed competitors
Also in this space
Clinical-stage biotech developing a monoclonal antibody targeting TSLP for inflammatory diseases.
Shares Life Sciences, Biotech
AI-powered patient-centric drug simulations to accelerate and de-risk drug development.
Shares Life Sciences, Clinical Trials
Omnix Medical is developing a novel platform for advanced wound care management.
Shares Life Sciences, Biopharmaceutical
AI-powered insights platform for life sciences and biotech workflows.
Shares Life Sciences, Biotech
Biotechnology company developing potentially curative cell therapies for cancer patients.
Shares Life Sciences, Biotech
Biotech company developing next-generation immunotherapy agents to unlock the immune system.
Shares Life Sciences, Biotech
Key facts
- Website
- eximore.co.il
- Headquarters
- Tel Aviv, Israel
- Founded
- 2014
- Employees
- 7
- Total funding
- $10M (Series A)
- Business model
- B2B
Funding rounds
| Date | Round | Amount | Lead investors |
|---|---|---|---|
| 1 Jul 2017 | Series A | $10M |
Tech stack
Detected on eximore.co.il, last scanned 22 Sept 2026. Run your own scan
- Frontend
- jQuery
- Analytics
- Google Tag Manager
- SEO
- Yoast SEO
- CMS / Builders
- WordPress
- Hosting
- Google Cloud
- Email provider
- Google Workspace
Eximore scores 8. Does yours?
That is its Ahrefs DR: the backlink strength of a domain, on the Ahrefs 0 to 100 scale. Paste your website and you get yours in about a minute.
Frequently asked
Is Eximore trustworthy and reputable?
StartupHub's Data Trust & Reputation score for Eximore is 74 out of 100, a generally safe rating, based on site security posture, privacy practices, malware and phishing checks, and public reputation signals.
How much funding has Eximore raised?
Eximore has raised a total of $10M in funding. The most recent round on record is Series A.
How many employees does Eximore have?
Eximore has approximately 7 people on record.
Public record
SEC filings, insider activity, nonprofit links and pay benchmarks for Eximore


